4Filing Date: Sep 24, 2026

Bio-techne

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0000914190-26-000139
Total Value$403.3K
Trades4
Insiders1

Transaction Details

BAUMGARTNER ROBERT V
Director·Direct
Exercise · Acquire
Common Stock
Shares+15.94K
Price$0.00
Total Value$0
Shares Owned After62.44K
Transaction DateSep 22, 2026
BAUMGARTNER ROBERT V
Director·Direct
Tax W/H · Dispose
Common Stock
Shares-5.56K
Price$72.55
Total Value$403.3K
Shares Owned After56.88K
Transaction DateSep 22, 2026
BAUMGARTNER ROBERT V
Director·Direct
Exercise · Dispose
Stock Options (Right to Buy)Derivative
Shares-15.94K
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateSep 22, 2026
Exercise Price$25.30
ExpiresOct 26, 2026
BAUMGARTNER ROBERT V
Director·Direct
Stock Options (Right to Buy)Derivative
Shares0
Price-
Total Value$0
Shares Owned After12.50K
Exercise Price$31.26
ExpiresOct 26, 2027
Holding Only

Post-Transaction Holdings

BAUMGARTNER ROBERT V · Director
SecuritySharesChange
Common Stock62.44K+10.38K (19.94%)
Stock Options (Right to Buy)0-15.94K (-100.00%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-22 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: BIO-TECHNE Corp (TECH) CIK: 0000842023 --- Reporting Owner --- Name: BAUMGARTNER ROBERT V CIK: 0001258704 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: +15,940 | Price: $0.00 Shares Owned After: 62,443 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-09-22 | Code: F (Payment of exercise/tax) Shares: -5,559 | Price: $72.55 Total Value: $403,305.45 Shares Owned After: 56,884 | Ownership: D (Direct) --- Derivative Transactions --- [Transaction #1] Security: Stock Options (Right to Buy) Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: -15,940 | Price: $0.00 Exercise Price: $25.30 Exercisable: N/A | Expires: 2026-10-26 Shares Owned After: 0 | Ownership: D (Direct) --- Holdings --- [Holding #1] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #2] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #3] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #4] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #5] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #6] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #7] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #8] Security: Stock Options (Right to Buy) Ownership: D (Direct) [Holding #9] Security: Stock Options (Right to Buy) Ownership: D (Direct) Footnotes: [F1] The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. --- Footnotes (Complete Index) --- F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. --- Signature --- /s/ /s/ Andrew Nick as Attorney-in-Fact for Robert V. Baumgartner pursuant to Power of Attorney previously filed. (2026-09-24)

keid analysis is for reference only and does not constitute investment advice.